Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02250950 · ClinicalTrials.gov registry record · Phase 2
An Examination of the Efficacy of a Self-Determination Theory and Motivational Interviewing Exercise Intervention
A Phase 2 study of Exercise Promotion, sponsored by Syracuse University.
- Completed
- Registry status
- Phase 2
- Development phase
- 57
- Enrollment target
- 1
- Study location
NCT02250950: Completed Phase 2 study of Exercise Promotion, sponsored by Syracuse University.
NCT02250950 is a Phase 2 study of Exercise Promotion that has completed, run by Syracuse University. The registered enrollment target is 57 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02250950, a Phase 2 study of Exercise Promotion, has completed, sponsored by Syracuse University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 57 participants
- Enrollment target
- 1
- Study location
Study Summary
The current study involves conducting an intervention based on self-determination theory (SDT) and motivational interviewing (MI) to promote physical activity in a racially-diverse sample. It is expected that this intervention will successfully increase physical activity in participants.
Conditions Studied
Interventions
- BEHAVIORAL MI and SDT Exercise Group
- BEHAVIORAL Non-MI and SDT Exercise Group
Study Locations (1)
New York
- Lauren S. Miller - Guilderland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2014-06 |
| Est. Completion | 2015-02 |
| Phase | Phase 2 |
What the finished NCT02250950 record still lists
NCT02250950 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 57 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (57% lower).
The record links to 1 condition, with Exercise Promotion appearing as the primary indexed condition, and to 2 interventions - of which MI and SDT Exercise Group is the first listed.
NCT02250950 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02250950 about?
NCT02250950 is a clinical study titled "An Examination of the Efficacy of a Self-Determination Theory and Motivational Interviewing Exercise Intervention". The current study involves conducting an intervention based on self-determination theory (SDT) and motivational interviewing (MI) to promote physical activity in a racially-diverse sample. It is expected that this intervention will successfully increase physical activity in participants.
What is the current status of trial NCT02250950?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 57 participants. The study started on 2014-06. Estimated completion is 2015-02.
What conditions does trial NCT02250950 study?
This clinical trial studies the following conditions: Exercise Promotion.
What interventions are being tested in trial NCT02250950?
The interventions under investigation include: MI and SDT Exercise Group (BEHAVIORAL), Non-MI and SDT Exercise Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT02250950?
This trial is sponsored by Syracuse University, which has 31 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02250950 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02250950's enrollment target sits among peer trials
57 1141st of 2000 higher than 855 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03521830 · 57 participants · Phase 2
Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
- NCT03587701 · 57 participants · Phase 2
Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease
- NCT04104126 · 57 participants · NA
Blood Flow Restriction Therapy in Achilles Injury
- NCT04703842 · 57 participants · Phase 1
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia